This site is intended for US Healthcare Professionals

Sign Up for Updates
Sign Up for Updates
Sign Up for Updates

Share your XDEMVY results

Upload and submit your images of patients before and after 6 weeks of XDEMVY treatment for Demodex blepharitis using the form below. Make sure your patient is looking down!

*Required

BEFORE treatment eyelid photo
of patient looking down
Drop files here or
Accepted file types: jpg, jpeg, gif, png, webp, heic, Max. file size: 8 MB, Max. files: 1.
    AFTER treatment eyelid photo
of patient looking down
    Drop files here or
    Accepted file types: jpg, jpeg, gif, png, webp, heic, Max. file size: 8 MB, Max. files: 1.
      Do not include patient identifiable information
      Do not include patient identifiable information
      REMOVE
      BEFORE treatment eyelid photo
of patient looking down
      Drop files here or
      Accepted file types: jpg, jpeg, gif, png, webp, heic, Max. file size: 8 MB, Max. files: 1.
        AFTER treatment eyelid photo
of patient looking down
        Drop files here or
        Accepted file types: jpg, jpeg, gif, png, webp, heic, Max. file size: 8 MB, Max. files: 1.
          Do not include patient identifiable information
          Do not include patient identifiable information
          REMOVE
          BEFORE treatment eyelid photo
of patient looking down
          Drop files here or
          Accepted file types: jpg, jpeg, gif, png, webp, heic, Max. file size: 8 MB, Max. files: 1.
            AFTER treatment eyelid photo
of patient looking down
            Drop files here or
            Accepted file types: jpg, jpeg, gif, png, webp, heic, Max. file size: 8 MB, Max. files: 1.
              Do not include patient identifiable information
              Do not include patient identifiable information
              REMOVE
              BEFORE treatment eyelid photo
of patient looking down
              Drop files here or
              Accepted file types: jpg, jpeg, gif, png, webp, heic, Max. file size: 8 MB, Max. files: 1.
                AFTER treatment eyelid photo
of patient looking down
                Drop files here or
                Accepted file types: jpg, jpeg, gif, png, webp, heic, Max. file size: 8 MB, Max. files: 1.
                  Do not include patient identifiable information
                  Do not include patient identifiable information
                  REMOVE
                  BEFORE treatment eyelid photo
of patient looking down
                  Drop files here or
                  Accepted file types: jpg, jpeg, gif, png, webp, heic, Max. file size: 8 MB, Max. files: 1.
                    AFTER treatment eyelid photo
of patient looking down
                    Drop files here or
                    Accepted file types: jpg, jpeg, gif, png, webp, heic, Max. file size: 8 MB, Max. files: 1.
                      Do not include patient identifiable information
                      Do not include patient identifiable information
                      Add another set of BEFORE and AFTER photos
                      Consent(Required)
                      Consent(Required)
                      This field is for validation purposes and should be left unchanged.

                      INDICATIONS AND USAGE
                      XDEMVY (lotilaner ophthalmic solution) 0.25% is indicated for the treatment of Demodex blepharitis.

                      IMPORTANT SAFETY INFORMATION:

                      WARNINGS AND PRECAUTIONS

                      Risk of Contamination: Do not allow the tip of the dispensing container to contact the eye, surrounding structures, fingers, or any other surface in order to minimize contamination of the solution. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.

                      Use with Contact Lenses: XDEMVY contains potassium sorbate, which may discolor soft contact lenses. Contact lenses should be removed prior to instillation of XDEMVY and may be reinserted 15 minutes following its administration.

                      ADVERSE REACTIONS: The most common adverse reaction with XDEMVY was instillation site stinging and burning which was reported in 10% of patients. Other ocular adverse reactions reported in less than 2% of patients were chalazion/hordeolum and punctate keratitis.

                      To report SUSPECTED ADVERSE REACTIONS, contact Tarsus Pharmaceuticals, Inc. at 1-888-421-4002 or the FDA at 1-800-FDA-1088 (www.fda.gov/medwatch).

                      Please see full Prescribing Information.

                      INDICATIONS AND USAGE
                      XDEMVY (lotilaner ophthalmic solution) 0.25% is indicated for the treatment of Demodex blepharitis.

                      IMPORTANT SAFETY INFORMATION:

                      WARNINGS AND PRECAUTIONS

                      Risk of Contamination: Do not allow the tip of the dispensing container to contact the eye, surrounding structures, fingers, or any other surface in order to minimize contamination of the solution. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.